CrystalGenomics Inks $2.6M
The Korea Seoul Life Science Fund has put $2.6 million into CrystalGenomics Inc., a clinical stage biopharmaceutical company based in Korea. The company has raised a total of $20 million across this round and previous bond issuances. The company will use the money for continued research and development.
13 January 2012•3 mins read
